This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
SEC.gov
EDGAR
Latest Filings
Filings search tools
Filing Detail
SEC Home
»
Company Search
»
Current Page
Form C
- Offering Statement:
SEC
Accession
No.
0001670254-20-001130
Filing Date
2020-12-10
Accepted
2020-12-10 12:28:19
Documents
10
Document Format Files
Seq
Description
Document
Type
Size
1
primary_doc.html
C
1
primary_doc.xml
C
9970
2
document_1.pdf
EX-99
12419412
3
document_2.pdf
EX-99
3513024
4
document_3.pdf
EX-99
8983521
5
document_4.pdf
EX-99
8356478
6
document_5.pdf
EX-99
697152
7
document_6.pdf
EX-99
1213730
8
document_7.pdf
EX-99
1129683
9
document_8.pdf
EX-99
18660783
10
documents_list.htm
EX-99
119
Complete submission text file
0001670254-20-001130.txt
73018875
Mailing Address
24 SMITH ROAD, UNIT 504
MIDLAND
TX
79705
Business Address
24 SMITH ROAD, UNIT 504
MIDLAND
TX
79705
5106982462
General Genomics Inc. (Filer)
CIK
:
0001834175 (see all company filings)
EIN.
:
851468728
Type:
C
| Act:
33
| File No.:
020-27309
| Film No.:
201380014